Log in

NASDAQ:VRMLVermillion Stock Price, Forecast & News

$4.00
-0.33 (-7.62 %)
(As of 07/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.65
Now: $4.00
$4.25
50-Day Range
$1.92
MA: $3.55
$5.25
52-Week Range
$0.35
Now: $4.00
$5.78
Volume1.32 million shs
Average Volume440,144 shs
Market Capitalization$389.51 million
P/E RatioN/A
Dividend YieldN/A
Beta3.47
Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.
Read More
Vermillion logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:VRML
CUSIPN/A
Phone512-519-0400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.54 million
Book Value$0.09 per share

Profitability

Net Income$-15,240,000.00
Net Margins-307.31%

Miscellaneous

Employees43
Market Cap$389.51 million
Next Earnings Date8/13/2020 (Estimated)
OptionableOptionable

Receive VRML News and Ratings via Email

Sign-up to receive the latest news and ratings for VRML and its competitors with MarketBeat's FREE daily newsletter.

Vermillion (NASDAQ:VRML) Frequently Asked Questions

How has Vermillion's stock been impacted by COVID-19 (Coronavirus)?

Vermillion's stock was trading at $0.84 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, VRML shares have increased by 376.2% and is now trading at $4.00. View which stocks have been most impacted by Coronavirus.

When is Vermillion's next earnings date?

Vermillion is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Vermillion.

How were Vermillion's earnings last quarter?

Vermillion, Inc. (NASDAQ:VRML) issued its earnings results on Thursday, August, 8th. The company reported ($0.06) earnings per share (EPS) for the quarter. The business had revenue of $1.14 million for the quarter. Vermillion had a negative net margin of 307.31% and a negative return on equity of 155.25%. View Vermillion's earnings history.

Has Vermillion been receiving favorable news coverage?

News headlines about VRML stock have been trending very negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Vermillion earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about Vermillion.

Are investors shorting Vermillion?

Vermillion saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 2,280,000 shares, an increase of 5.1% from the May 31st total of 2,170,000 shares. Based on an average daily trading volume, of 566,000 shares, the short-interest ratio is currently 4.0 days. Currently, 4.5% of the shares of the stock are sold short. View Vermillion's Current Options Chain.

Who are some of Vermillion's key competitors?

What other stocks do shareholders of Vermillion own?

Who are Vermillion's key executives?

Vermillion's management team includes the following people:
  • Ms. Valerie Barber Palmieri, CEO, Pres & Director (Age 58)
  • Mr. Robert Harry Beechey CPA, Chief Financial Officer (Age 56)
  • Mr. Chris Goulart, Sr. VP of Commercial Operations

What is Vermillion's stock symbol?

Vermillion trades on the NASDAQ under the ticker symbol "VRML."

How do I buy shares of Vermillion?

Shares of VRML can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vermillion's stock price today?

One share of VRML stock can currently be purchased for approximately $4.00.

How big of a company is Vermillion?

Vermillion has a market capitalization of $389.51 million and generates $4.54 million in revenue each year. Vermillion employs 43 workers across the globe.

What is Vermillion's official website?

The official website for Vermillion is www.vermillion.com.

How can I contact Vermillion?

Vermillion's mailing address is 12117 BEE CAVES ROAD BUILDING THREE SUITE 100, AUSTIN TX, 78738. The company can be reached via phone at 512-519-0400 or via email at [email protected]

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.